These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 12600268)
1. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor. Malykh EV; Larionova NI Biochemistry (Mosc); 2002 Dec; 67(12):1383-7. PubMed ID: 12600268 [TBL] [Abstract][Full Text] [Related]
2. Acylation of Bowman-Birk soybean proteinase inhibitor by unsaturated fatty acid derivatives. Malykh EV; Tiourina OP; Larionova NI Biochemistry (Mosc); 2001 Apr; 66(4):444-8. PubMed ID: 11403653 [TBL] [Abstract][Full Text] [Related]
3. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390 [TBL] [Abstract][Full Text] [Related]
4. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors. Weder JK; Hinkers SC J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops. Mao Y; Lai C; Vogtentanz G; Schmidt B; Day T; Miller J; Brandon DL; Chen D Protein J; 2005 Jul; 24(5):275-82. PubMed ID: 16284725 [TBL] [Abstract][Full Text] [Related]
7. Interaction of human leukocyte elastase with plasma fibronectin and its inhibition by soybean Bowman-Birk protease inhibitor. Larionova NI; Balabushevitch NG; Zhatikov PA Biochemistry (Mosc); 1998 Sep; 63(9):1078-82. PubMed ID: 9795279 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte elastase inhibition by Bowman-Birk soybean inhibitor. Discrimination of the inhibition mechanisms. Larionova NI; Gladysheva IP; Gladyshev DP FEBS Lett; 1997 Mar; 404(2-3):245-8. PubMed ID: 9119072 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor]. Larionova NI; Gladysheva IP; Tikhonova TV; Kazanskaia NF Biokhimiia; 1993 Aug; 58(9):1437-44. PubMed ID: 8218567 [TBL] [Abstract][Full Text] [Related]
10. Effects of Disulfide Bond Reduction on the Conformation and Trypsin/Chymotrypsin Inhibitor Activity of Soybean Bowman-Birk Inhibitor. He H; Li X; Kong X; Zhang C; Hua Y; Chen Y J Agric Food Chem; 2017 Mar; 65(11):2461-2467. PubMed ID: 28249116 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors. Domingo GJ; Leatherbarrow RJ; Freeman N; Patel S; Weir M Int J Pept Protein Res; 1995 Jul; 46(1):79-87. PubMed ID: 7558601 [TBL] [Abstract][Full Text] [Related]
12. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Clemente A; Moreno FJ; Marín-Manzano Mdel C; Jiménez E; Domoney C Mol Nutr Food Res; 2010 Mar; 54(3):396-405. PubMed ID: 19885848 [TBL] [Abstract][Full Text] [Related]
13. The biochemical and functional food properties of the bowman-birk inhibitor. Losso JN Crit Rev Food Sci Nutr; 2008 Jan; 48(1):94-118. PubMed ID: 18274967 [TBL] [Abstract][Full Text] [Related]
14. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G]. Gladysheva IP; Larionova NI; Gladyshev DP; Tikhonova TV; Kazanskaia NF Biokhimiia; 1994 Apr; 59(4):513-8. PubMed ID: 8018773 [TBL] [Abstract][Full Text] [Related]
15. Peptide mimics of the Bowman-Birk inhibitor reactive site loop. McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158 [TBL] [Abstract][Full Text] [Related]
16. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans. Birk Y Int J Pept Protein Res; 1985 Feb; 25(2):113-31. PubMed ID: 3886572 [TBL] [Abstract][Full Text] [Related]
17. [Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide]. Larionova NI; Gladysheva IP; Topchieva IN; Kazanskaia NF Biokhimiia; 1993 Oct; 58(10):1658-64. PubMed ID: 8268307 [TBL] [Abstract][Full Text] [Related]
18. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43. Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds. Scarafoni A; Consonni A; Galbusera V; Negri A; Tedeschi G; Rasmussen P; Magni C; Duranti M Phytochemistry; 2008 Jun; 69(9):1820-5. PubMed ID: 18474386 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of soybean Bowman-Birk inhibitor from different sources. Gladysheva IP; Balabushevich NG; Moroz NA; Larionova NI Biochemistry (Mosc); 2000 Feb; 65(2):198-203. PubMed ID: 10713547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]